Physician profile
Sue E Gragera
NPI 1528698834
$434.75
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $211 · 2022: $72.23 · 2023: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $162.98 | 2021-2022 | |
| Lilly USA, LLC | $58.48 | 2021-2022 | |
| Glaxosmithkline, LLC. | $48.95 | 2023 | Bexsero, Fluarix Quadrivalent, Pediarix |
| Biomarin Pharmaceutical INC. | $33.25 | 2023 | Voxzogo 1.2mg |
| Cranial Technologies, INC | $30.68 | 2021-2023 | Doc Band |
| Hologic Sales and Service, LLC | $20.64 | 2021 | |
| Pfizer INC. | $18.60 | 2023 | |
| Merck Sharp & Dohme LLC | $18.35 | 2023 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Novo Nordisk INC | $15.49 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $14.68 | 2023 | Kristalose |
| Shield Therapeutics INC | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sue Gragera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.